TY  - GEN
AU  - George,Mark S
AU  - Molnar,Christine E
AU  - Grenesko,Emily L
AU  - Anderson,Berry
AU  - Mu,Qiwen
AU  - Johnson,Kevin
AU  - Nahas,Ziad
AU  - Knable,Michael
AU  - Fernandes,Prabhavathi
AU  - Juncos,Jorge
AU  - Huang,Xuemei
AU  - Nichols,David E
AU  - Mailman,Richard B
TI  - A single 20 mg dose of dihydrexidine (DAR-0100), a full dopamine D1 agonist, is safe and tolerated in patients with schizophrenia
SN  - 0920-9964
PY  - 2007///0830
KW  - Adult
KW  - Antipsychotic Agents
KW  - adverse effects
KW  - Brain
KW  - blood supply
KW  - Cross-Over Studies
KW  - Dopamine Agonists
KW  - Dose-Response Relationship, Drug
KW  - Double-Blind Method
KW  - Drug Therapy, Combination
KW  - Female
KW  - Humans
KW  - Image Processing, Computer-Assisted
KW  - Injections, Subcutaneous
KW  - Magnetic Resonance Imaging
KW  - Male
KW  - Memory, Short-Term
KW  - drug effects
KW  - Middle Aged
KW  - Neuropsychological Tests
KW  - Oxygen
KW  - blood
KW  - Phenanthridines
KW  - administration & dosage
KW  - Pilot Projects
KW  - Psychiatric Status Rating Scales
KW  - Receptors, Dopamine D1
KW  - agonists
KW  - Regional Blood Flow
KW  - Schizophrenia
KW  - diagnosis
KW  - Treatment Outcome
N1  - Publication Type: Journal Article; Randomized Controlled Trial
UR  - https://doi.org/10.1016/j.schres.2007.03.011
ER  -